Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Aagaard

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Molecular Therapy. Nucleic Acids|March 3, 2019
Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene TherapyAnne Louise Askou, Sidsel Alsing, Josephine N E Benckendorff, et al.
Nucleic Acids Research|July 31, 2007
Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISCDaniela Castanotto, Kumi Sakurai, Robert Lingeman, et al.
Human Gene Therapy Methods|August 18, 2017
Suppression of Choroidal Neovascularization in Mice by Subretinal Delivery of Multigenic Lentiviral Vectors Encoding Anti-Angiogenic MicroRNAsAnne Louise Askou, Josephine Natalia Esther Benckendorff, Andreas Holmgaard, et al.
Stem Cell Research|April 18, 2017
Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP geneLise Bols Toustrup, Yan Zhou, Helene Kvistgaard, et al.
RNA (New York, N.Y.)|May 11, 2017
Improved microRNA suppression by WPRE-linked tough decoy microRNA spongesAnne Kruse Hollensen, Rune Thomsen, Rasmus O Bak, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factorsAnne Louise Askou, Lars Aagaard, Corinne Kostic, et al.
Human Gene Therapy Methods|July 24, 2015
Robust Lentiviral Gene Delivery But Limited Transduction Capacity of Commonly Used Adeno-Associated Viral Serotypes in Xenotransplanted Human SkinMaria Jakobsen, Anne Louise Askou, Karin Stenderup, et al.
Molecular Therapy. Nucleic Acids|October 23, 2018
Enhanced Tailored MicroRNA Sponge Activity of RNA Pol II-Transcribed TuD Hairpins Relative to Ectopically Expressed ciRS7-Derived circRNAsAnne Kruse Hollensen, Sofie Andersen, Karina Hjorth, et al.
Molecular Therapy. Nucleic Acids|August 16, 2023
25 years of maturation: A systematic review of RNAi in the clinicIda Juhl Corydon, Bjørn Kristensen Fabian-Jessing, Thomas Stax Jakobsen, et al.
Investigative Ophthalmology & Visual Science|August 9, 2022
Animal Models of Choroidal Neovascularization: A Systematic ReviewBjørn K Fabian-Jessing, Thomas Stax Jakobsen, Emilie Grarup Jensen, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Molecular Therapy. Nucleic Acids|March 3, 2019
Suppression of Choroidal Neovascularization by AAV-Based Dual-Acting Antiangiogenic Gene TherapyAnne Louise Askou, Sidsel Alsing, Josephine N E Benckendorff, et al.
Nucleic Acids Research|July 31, 2007
Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISCDaniela Castanotto, Kumi Sakurai, Robert Lingeman, et al.
Human Gene Therapy Methods|August 18, 2017
Suppression of Choroidal Neovascularization in Mice by Subretinal Delivery of Multigenic Lentiviral Vectors Encoding Anti-Angiogenic MicroRNAsAnne Louise Askou, Josephine Natalia Esther Benckendorff, Andreas Holmgaard, et al.
Stem Cell Research|April 18, 2017
Induced pluripotent stem cells derived from a patient with autosomal dominant familial neurohypophyseal diabetes insipidus caused by a variant in the AVP geneLise Bols Toustrup, Yan Zhou, Helene Kvistgaard, et al.
RNA (New York, N.Y.)|May 11, 2017
Improved microRNA suppression by WPRE-linked tough decoy microRNA spongesAnne Kruse Hollensen, Rune Thomsen, Rasmus O Bak, et al.
Molecular Therapy. Methods & Clinical Development|June 9, 2015
Multigenic lentiviral vectors for combined and tissue-specific expression of miRNA- and protein-based antiangiogenic factorsAnne Louise Askou, Lars Aagaard, Corinne Kostic, et al.
Human Gene Therapy Methods|July 24, 2015
Robust Lentiviral Gene Delivery But Limited Transduction Capacity of Commonly Used Adeno-Associated Viral Serotypes in Xenotransplanted Human SkinMaria Jakobsen, Anne Louise Askou, Karin Stenderup, et al.
Molecular Therapy. Nucleic Acids|October 23, 2018
Enhanced Tailored MicroRNA Sponge Activity of RNA Pol II-Transcribed TuD Hairpins Relative to Ectopically Expressed ciRS7-Derived circRNAsAnne Kruse Hollensen, Sofie Andersen, Karina Hjorth, et al.
Molecular Therapy. Nucleic Acids|August 16, 2023
25 years of maturation: A systematic review of RNAi in the clinicIda Juhl Corydon, Bjørn Kristensen Fabian-Jessing, Thomas Stax Jakobsen, et al.
Investigative Ophthalmology & Visual Science|August 9, 2022
Animal Models of Choroidal Neovascularization: A Systematic ReviewBjørn K Fabian-Jessing, Thomas Stax Jakobsen, Emilie Grarup Jensen, et al.
Pageof 5